Quince Therapeutics released FY2024 Q3 earnings on Nov 13, 2024 (EST): Actual Revenue USD 0 (Forecast USD 0), Actual EPS USD -25.45 (Forecast USD -31)

Brief Summary

Quince Therapeutics reported its 2024 Q3 financial results with zero revenue and a net loss of $5.49 million, though its EPS of -$25.447 performed better than the market’s expected -$31.

Impact of The News

Event Overview and Market Expectations